Open original FDA record ↗Recall record
- FDA identifier
- Z-2537-2020
- Company in FDA record
- Vitalconnect Inc.
- FDA classification date
- Jul 10, 2020
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
A healthcare provider (HCP) noticed a patient had a lowered historic SpO2 reading that the software should have triggered a notification to the care team, but no notification was found. A software defect was encountered causing the lack of notification. The defect could result in exposing a patient to potential hypoxia for a short window of time. The firm is correcting the software to bring the performance back into compliance with specifications.
Source facts
- Action
- On May 21, 2020, the firm sent a "Urgent: Medical Device Recall" notification to all affected customers via E-mail and mail. The letter stated, that the third party Sp02 continuous device notifications may not indicate an alert as intended. Therefore, the health care provider may not be notified to check the patient. Potential Hazards: A patient may have hypoxia and the designated health care provider may not be notified. The firm will be turning off the ability to set custom notifications containing continuous SP02 until the issue is resolved. The firm tells customers to monitor the patients for SPO2, as if the patients are not connected to the recalled device. The customers are informed to acknowledge the receipt of this notification by E-mail or via mail to the firm, email to: cmerrell@vitalconnect.com and if any questions, then contact: Tony Wilder at phone: (408) 963-4600 or support@vitalconnect.com
- Initiated
- 2020-05-21
- Root cause
- Software Design Change
- Terminated
- 2021-05-13
- Distribution
- U.S. Nationwide distribution including in the states of NJ, NY, VA, OUS: None
- Recall number
- Z-2537-2020
- Recall status
- Terminated
- CDRH record ID
- 181805
- FDA classified
- 2020-07-10
- Recall event number
- 85802